Pennsylvania Xarelto Plaintiffs Request to Amend the Master Complaint

  • Xarelto Medical Record Review & Outsourcing Services

More than 1,800 product liability claims involving Johnson & Johnson and its subsidiary Janssen Pharmaceuticals’ blood thinner Xarelto are awaiting trial in Philadelphia Court of Common Pleas, and trials for three Xarelto lawsuits are expected to begin this April.

A request to make changes to the Master Complaint was put before the Philadelphia Court of Common Pleas by the remaining Pennsylvania plaintiffs to give them time to “reorganize the allegations and provide more details about the actions and inactions that form the bases of already-existing causes of action.” This request is strongly opposed by the defendants.

There are nearly 18,000 Xarelto federal product liability claims consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana.

We are social:



Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...


NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...



CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...


CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...


NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

MTMP Spring Conference - 2018
Neural IT Team got to pose with Mike Papantonio at the successful book signing event of ‘Law And
Neural IT Celebrates 14 Jubilant years of Accomplishments & Achievements!
Neural IT Celebrates 14 Jubilant years of Accomplishments & Achievements!
2nd Quarter 2018 Rewards & Recognition Program Celebrations
2nd Quarter 2018 ‘Rewards & Recognition Program’ Celebrations at NEURAL IT

Latest Tweets